Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Aug 19 2024

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE ·

On 6ix: 6ix.com/news/glenmark-pharmaceuticals-limited-press-release-aug-19-2024

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2024, titled "Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases